In today’s briefing:
- Detailing KRX Market Alerts & Passive Flow Plays
- Kospi Index Options Weekly (Mar 17 – 21): Extending Gains and Outperformance
Detailing KRX Market Alerts & Passive Flow Plays
- HLB Life Science faces delisting if it stays in ATTENTION for four years or gets a disclaimer in an audit—barring surprises, there’s still runway before it’s a real threat.
- HLB Inc getting ATTENTION in May looks likely, as KRX factors in frequent correction disclosures—HLB’s history with Rivoceranib filings and the failed FDA bid add to the risk.
- If HLB Inc. gets ATTENTION in May and drops from KOSDAQ 150, VIOL (335890 KS) steps in—worth positioning ahead of late April.
Kospi Index Options Weekly (Mar 17 – 21): Extending Gains and Outperformance
- A weekly recap of volatility and price metrics, including option volumes, volatility trends, the spot/implied relationship, and open interest statistics.
- Kospi extended its gains after a strong start, maintaining its position as a relative outperformer.
- We examine Kospi’s recent outperformance against comparable indices as well as SP500.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
